Franklin Resources’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
Other funds holding TPST
EC
RSCM
Franklin Resources's TPST Position: Q1 2023 in Review
Franklin Resources sold out of Tempest Therapeutics (TPST) in Q1 2023, closing a stake of 870 shares — an estimated $13.1K sold.
Franklin Resources first reported a position in TPST in Q3 2013 and held it in 25 quarters. The position peaked at $18.4M in Q2 2015. 17 funds tracked by Wall St. Rank hold TPST as of Q1 2023.
- Franklin Resources reported no remaining Tempest Therapeutics position as of Q1 2023 after selling out during the quarter.
- Franklin Resources sold 870 Tempest Therapeutics shares in Q1 2023, an estimated $13.1K.
- Franklin Resources first reported a position in Tempest Therapeutics in Q3 2013 and held it in 25 quarters.
- Franklin Resources's Tempest Therapeutics position peaked at $18.4M in Q2 2015.
- 17 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2023.
Based on Franklin Resources's 13F filing for Q1 2023, filed 12 May 2023.